title: Competitive equality of donor cells expressing a disparate MHC antigen following stem cell-enriched bone marrow transplantation.
abstract: BACKGROUND
  Bone marrow cells expressing foreign MHC antigens survive poorly after transplantation. Stable mixed hematopoietic chimerism requires reconstitution with a relatively large number of foreign bone marrow cells and intensive depletion of host cells. In addition, when foreign MHC-transduced autologous bone marrow cells are transplanted, prolonged hematopoietic transgene expression requires extensive host conditioning. The competitive disadvantage associated with engraftment of donor cells expressing foreign MHC antigens is thought to result from a defect in engraftment secondary to donor-host incompatibility or immunologic resistance by the host.
  
  
  METHODS
  We used a limiting-dilution competitive repopulation assay with cells from HLA-A2.1 transgenic mice to determine whether and to what extent foreign MHC antigen expression impairs engraftment in C57BL/6 hosts. Transplants were performed with Hoechst 33342 fluorescence-sorted side population (SP) cells, a subset of bone marrow enriched for stem cells. RESULTS.: Transplantation with 250 stem cell-enriched HLA-A2.1-transgenic side population cells successfully competed with nearly 5000 host C57BL/6 side population cells to produce stable long-term mixed chimerism. There was a direct relationship between the number of transplanted donor HLA-A2-expressing cells and the percentage of HLA-A2-expressing cells in the peripheral blood of reconstituted C57BL/6 mice (r2=0.1799, P=0.031). This correlation was maintained in secondary transplant recipients.
  
  
  CONCLUSIONS
  HLA-A2-expressing hematopoietic cells do not have an engraftment defect when transplanted into C57BL/6 hosts and immunologic resistance did not limit chimerism following lethal irradiation. These results may have relevance to understanding long-term gene expression after hematopoietic stem cell based gene therapy.
authors.affiliation: Departments of Surgery, University of Nebraska Medical Center, Omaha, Nebraska 68198-3285, USA.
authors.forename: Jia-Lin
authors.initials: JL
authors.lastname: Zhang
authors.forename: Jin
authors.initials: J
authors.lastname: Cai
authors.forename: John D
authors.initials: JD
authors.lastname: Jackson
authors.forename: Shannon
authors.initials: S
authors.lastname: Walls
authors.forename: Charles A
authors.initials: CA
authors.lastname: Kuszynski
authors.forename: Ira J
authors.initials: IJ
authors.lastname: Fox
mesh_terms: D000818:Animals; D001773:Blood Cells / Q000378:metabolism; D001854:Bone Marrow Cells / Q000378:metabolism*; D016026:Bone Marrow Transplantation; D015789:HLA-A2 Antigen / Q000097:blood / Q000378:metabolism*; D018380:Hematopoietic Stem Cell Transplantation; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011184:Postoperative Period; D014019:Tissue Donors; D018183:Transplantation Chimera; D014181:Transplantation Immunology; D023001:Transplantation Tolerance
chemical_list: D015789:HLA-A2 Antigen